Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sage/Biogen Zuranolone Study Shows More Efficacy, But Higher Toxicity
Commercial Prospects Still Murky
Dec 01 2021
•
By
Alaric DeArment
Sage/Biogen released new data from the 50mg cohort of the SHORELINE study of zuranolone • Source: Shutterstock
More from Neurological
More from Therapeutic Category